GE HealthCare Technologies Inc. $GEHC Position Trimmed by Employees Retirement System of Texas

Employees Retirement System of Texas trimmed its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 22.9% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 535,700 shares of the company’s stock after selling 159,300 shares during the quarter. Employees Retirement System of Texas’ holdings in GE HealthCare Technologies were worth $43,938,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Western Wealth Management LLC raised its holdings in GE HealthCare Technologies by 2.4% during the 4th quarter. Western Wealth Management LLC now owns 5,240 shares of the company’s stock worth $430,000 after purchasing an additional 125 shares during the last quarter. United Community Bank raised its holdings in GE HealthCare Technologies by 10.2% during the 4th quarter. United Community Bank now owns 1,410 shares of the company’s stock worth $116,000 after purchasing an additional 130 shares during the last quarter. Thoma Capital Management LLC raised its holdings in GE HealthCare Technologies by 1.4% during the 4th quarter. Thoma Capital Management LLC now owns 9,918 shares of the company’s stock worth $814,000 after purchasing an additional 136 shares during the last quarter. Colonial Trust Advisors raised its holdings in GE HealthCare Technologies by 11.1% during the 3rd quarter. Colonial Trust Advisors now owns 1,391 shares of the company’s stock worth $104,000 after purchasing an additional 139 shares during the last quarter. Finally, Norinchukin Bank The raised its holdings in GE HealthCare Technologies by 0.4% during the 3rd quarter. Norinchukin Bank The now owns 38,913 shares of the company’s stock worth $2,922,000 after purchasing an additional 149 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have issued reports on GEHC. Evercore set a $80.00 price target on shares of GE HealthCare Technologies in a report on Thursday, April 30th. BTIG Research lowered their price target on shares of GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating for the company in a report on Wednesday, April 29th. BNP Paribas Exane lowered their price target on shares of GE HealthCare Technologies from $95.00 to $88.00 in a report on Friday, May 1st. Mizuho lowered their price target on shares of GE HealthCare Technologies from $90.00 to $80.00 in a report on Thursday, April 30th. Finally, Wells Fargo & Company lowered their price target on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a report on Thursday, April 30th. Nine research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $80.21.

Insider Buying and Selling

In related news, Director Rodney F. Hochman acquired 1,618 shares of the stock in a transaction dated Tuesday, May 12th. The stock was bought at an average price of $62.03 per share, for a total transaction of $100,364.54. Following the purchase, the director directly owned 1,618 shares of the company’s stock, valued at $100,364.54. The trade was a ∞ increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Watkin Phoebe L. Yang acquired 1,000 shares of the stock in a transaction dated Friday, May 8th. The stock was bought at an average price of $63.01 per share, with a total value of $63,010.00. Following the purchase, the director directly owned 13,702 shares in the company, valued at $863,363.02. This represents a 7.87% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have purchased a total of 21,847 shares of company stock worth $1,361,355 over the last ninety days. 0.36% of the stock is owned by company insiders.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC opened at $64.18 on Wednesday. The company has a fifty day moving average of $68.20 and a 200-day moving average of $76.10. The firm has a market capitalization of $29.19 billion, a P/E ratio of 15.35, a P/E/G ratio of 1.45 and a beta of 0.74. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. GE HealthCare Technologies Inc. has a twelve month low of $58.75 and a twelve month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). The company had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business’s revenue was up 7.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.